Comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemia

Trial Profile

Comparison of pitavastatin versus EPA on lipid-lowering effect in patients with dyslipidemia

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2015

At a glance

  • Drugs Eicosapentaenoic acid (Primary) ; Pitavastatin (Primary)
  • Indications Dyslipidaemias
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 28 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top